✦ LIBER ✦

Delapril versus manidipine in hypertensive therapy to halt the type-2-diabetes-mellitus-associated nephropathy

✍ Scribed by Teruo Shiba; Masahiro Inoue; Hisaya Tada; Yoichi Hayashi; Yukichi Okuda; Rie Fujita; Fuminori Makino; Chieko Takahasi; Shigeru Kageyama; Shinichi Kitamura; Yasuhiko Iwamoto

Book ID: 117371704
Publisher: Elsevier Science
Year: 2000
Tongue: English
Weight: 107 KB
Volume: 47
Category: Article
ISSN: 0168-8227
DOI: 10.1016/s0168-8227(99)00114-x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

TheHFEgene is associated to an earlier a

TheHFEgene is associated to an earlier age of onset and to the presence of diabetic nephropathy in diabetes mellitus type 2

✍ Rafael Oliva; Anna Novials; Mayka Sánchez; Marga Villa; Mercedes Ingelmo; Mónica 📂 Article 📅 2004 🏛 Springer 🌐 English ⚖ 140 KB

Association of the Cluster of Genetic Ri

Association of the Cluster of Genetic Risk Factors in Loci Related to Glycoxidation with Diabetic Nephropathy in Type 2 Diabetes Mellitus

✍ K KANKOVÁ; A STEJSKALOVÁ; L PÁCAL; M HERTLOVÁ; D KRUSOVÁ 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 38 KB

Hypertension resistant to antihypertensi

Hypertension resistant to antihypertensive agents commonly occurs with the progression of diabetic nephropathy in Japanese patients with type 2 diabetes mellitus: a prospective observational study

✍ Ito, Hiroyuki; Mifune, Mizuo; Abe, Mariko; Oshikiri, Koshiro; Antoku, Shinichi; 📂 Article 📅 2012 🏛 BioMed Central 🌐 English ⚖ 282 KB

196: Cost-Effectiveness of Aliskiren as

196: Cost-Effectiveness of Aliskiren as Add on to Losartan and Optimal Antihypertensive Therapy in Patients with Type 2 Diabetes, Hypertension and Nephropathy in the UK Setting

✍ James L. Palmer; Veronica C. Munk; Robert W. Kotchie; Gabor Vincze; Alan Charney 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 184 KB

PCV34 THE COST-EFFECTIVENESS OF ALISKIRE

PCV34 THE COST-EFFECTIVENESS OF ALISKIREN AS ADD ON TO LOSARTAN AND OPTIMAL ANTIHYPERTENSIVE THERAPY IN PATIENTS WITH TYPE 2 DIABETES, HYPERTENSION AND NEPHROPATHY IN THE UNITED KINGDOM SETTING

✍ JL Palmer; VC Munk; R Kotchie; G Vincze; Charney k; D Tucker; L Annemans 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 75 KB

Long-term clinical and economic outcomes

Long-term clinical and economic outcomes associated with liraglutide versus sitagliptin therapy when added to metformin in the treatment of type 2 diabetes: a CORE Diabetes Model analysis

✍ Lee, Won Chan; Samyshkin, Yevgeniy; Langer, Jakob; Palmer, James L. 📂 Article 📅 2012 🏛 Informa plc 🌐 English ⚖ 279 KB